CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Oncolys Biopharma Inc Company Snapshot
Oncolys Biopharma Inc operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Oncolys Biopharma Inc with three other companies in this sector in Japan: D.Western Therapeutics Institute Incorporation (2017 sales of 254.03 million Japanese Yen [US$2.25 million] of which 100% was Drug Research and Development), Chiome Bioscience Inc (259.90 million Japanese Yen [US$2.31 million] of which 77% was base plate technolgy license business), and Nanocarrier Company Limited (218.69 million Japanese Yen [US$1.94 million] of which 100% was Research and Development).

Sales Analysis. During the year ended December of 2017, sales at Oncolys Biopharma Inc were ¥229.14 million (US$2.03 million). This is an increase of 28.5% versus 2016, when the company's sales were ¥178.31 million. This was the fourth straight year of sales growth at Oncolys Biopharma Inc.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Oncolys Biopharma Inc
  Stock Performance Chart for Oncolys Biopharma Inc
 
  Stock Data: Recent Stock Performance:
  Current Price (12/7/2018): 795.00
(Figures in Japanese Yen)
1 Week 13.7%   13 Weeks 19.7%  
4 Weeks 29.3%   52 Weeks 15.6%  
 
Oncolys Biopharma Inc Key Data:
  Ticker: 4588 Country: Japan
  Exchanges: TYO Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2017 Sales 229,139,000
(Year Ending Jan 2018).
Employees: 29
  Currency: Japanese Yen Market Cap: 9,988,380,000
  Fiscal Yr Ends: December Shares Outstanding: 12,564,000
  Share Type: Common Closely Held Shares: 2,075,800
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.